177 related articles for article (PubMed ID: 18601603)
1. Polymorphisms of CYP17A1, CYP19, and androgen in Brazilian women with uterine leiomyomas.
Rosa FE; Canevari Rde A; Ambrosio EP; Ramos Cirilo PD; Pontes A; Rainho CA; Rogatto SR
Clin Chem Lab Med; 2008; 46(6):814-23. PubMed ID: 18601603
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms in the CYP19 and AR genes--relation to bone mass and longitudinal bone changes in postmenopausal women with or without hormone replacement therapy: The Danish Osteoporosis Prevention Study.
Tofteng CL; Kindmark A; Brändström H; Abrahamsen B; Petersen S; Stiger F; Stilgren LS; Jensen JE; Vestergaard P; Langdahl BL; Mosekilde L;
Calcif Tissue Int; 2004 Jan; 74(1):25-34. PubMed ID: 14517714
[TBL] [Abstract][Full Text] [Related]
3. PSA and androgen-related gene (AR, CYP17, and CYP19) polymorphisms and the risk of adenocarcinoma at prostate biopsy.
dos Santos RM; de Jesus CM; Trindade Filho JC; Trindade JC; de Camargo JL; Rainho CA; Rogatto SR
DNA Cell Biol; 2008 Sep; 27(9):497-503. PubMed ID: 18491956
[TBL] [Abstract][Full Text] [Related]
4. Genetic polymorphisms associated with steroids metabolism and insulin action in polycystic ovary syndrome.
Ramos Cirilo PD; Rosa FE; Moreira Ferraz MF; Rainho CA; Pontes A; Rogatto SR
Gynecol Endocrinol; 2012 Mar; 28(3):190-4. PubMed ID: 21824047
[TBL] [Abstract][Full Text] [Related]
5. Semen quality is influenced by androgen receptor and aromatase gene synergism.
Lazaros L; Xita N; Takenaka A; Sofikitis N; Makrydimas G; Stefos T; Kosmas I; Zikopoulos K; Hatzi E; Georgiou I
Hum Reprod; 2012 Dec; 27(12):3385-92. PubMed ID: 23001776
[TBL] [Abstract][Full Text] [Related]
6. Polymorphic (CAG)n repeats in the androgen receptor gene: a risk marker for endometriosis and uterine leiomyomas.
Shaik NA; Govindan S; Kodati V; Rao KP; Hasan Q
Hematol Oncol Stem Cell Ther; 2009; 2(1):289-93. PubMed ID: 20063560
[TBL] [Abstract][Full Text] [Related]
7. Androgen receptor trinucleotide polymorphism in leiomyoma.
Hsieh YY; Chang CC; Tsai FJ; Lin CC; Yeh LS; Peng CT
J Assist Reprod Genet; 2004 Dec; 21(12):453-7. PubMed ID: 15704521
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms of estrogen-metabolizing genes and breast cancer risk: a multigenic study.
Han DF; Zhou X; Hu MB; Xie W; Mao ZF; Chen DE; Liu F; Zheng F
Chin Med J (Engl); 2005 Sep; 118(18):1507-16. PubMed ID: 16232327
[TBL] [Abstract][Full Text] [Related]
9. CAG repeats in the androgen receptor gene are shorter in patients with pulmonary, esophageal or bladder carcinoma and longer in women with uterine leiomyoma.
Teng XY; Liu GQ; Diao XL; Wu ZY; Li L; Zhang W; Zhang X; Su Q
Oncol Rep; 2010 Mar; 23(3):811-8. PubMed ID: 20127024
[TBL] [Abstract][Full Text] [Related]
10. The CYP17 MspA1 polymorphism is not associated with an increased risk of uterine leiomyomas in a Japanese population.
Tsujino T; Ohara N; Yoshida S; Kennedy S; Takemura N; Deguchi M; Maruo T
Gynecol Endocrinol; 2006 Feb; 22(2):87-91. PubMed ID: 16603433
[TBL] [Abstract][Full Text] [Related]
11. Expression of size-polymorphic androgen receptor gene in uterine leiomyoma according to the number of cytosine, adenine, and guanine repeats in androgen receptor alleles.
Fujimoto J; Hirose R; Sakaguchi H; Tamaya T
Tumour Biol; 2000; 21(1):33-7. PubMed ID: 10601839
[TBL] [Abstract][Full Text] [Related]
12. The association between genetic polymorphisms in CYP19 and breast cancer risk in Korean women.
Kim JY; Lee CS; Kim HO; Jo YH; Lee J; Jung MH; Baik HH; Choe W; Kang I; Yoon KS
Oncol Rep; 2009 Sep; 22(3):487-92. PubMed ID: 19639193
[TBL] [Abstract][Full Text] [Related]
13. Solitary and multiple uterine leiomyomas among Caucasian women: two different disorders?
Pakiz M; Potocnik U; But I
Fertil Steril; 2010 Nov; 94(6):2291-5. PubMed ID: 20171624
[TBL] [Abstract][Full Text] [Related]
14. A tetranucleotide repeat polymorphism in CYP19 and breast cancer risk.
Haiman CA; Hankinson SE; Spiegelman D; De Vivo I; Colditz GA; Willett WC; Speizer FE; Hunter DJ
Int J Cancer; 2000 Jul; 87(2):204-10. PubMed ID: 10861475
[TBL] [Abstract][Full Text] [Related]
15. Prostate carcinoma risk and allelic variants of genes involved in androgen biosynthesis and metabolism pathways.
Latil AG; Azzouzi R; Cancel GS; Guillaume EC; Cochan-Priollet B; Berthon PL; Cussenot O
Cancer; 2001 Sep; 92(5):1130-7. PubMed ID: 11571725
[TBL] [Abstract][Full Text] [Related]
16. CYP17 and CYP19 genetic polymorphisms in endometrial cancer: association with intratumoral aromatase activity.
Berstein LM; Imyanitov EN; Kovalevskij AJ; Maximov SJ; Vasilyev DA; Buslov KG; Sokolenko AP; Iyevleva AG; Chekmariova EV; Thijssen JH
Cancer Lett; 2004 Apr; 207(2):191-6. PubMed ID: 15072828
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms in androgen metabolism genes AR, CYP1B1, CYP19, and SRD5A2and prostate cancer risk and aggressiveness in Bulgarian patients.
Kachakova D; Mitkova A; Popov E; Beltcheva O; Vlahova A; Dikov T; Christova S; Mitev V; Slavov C; Kaneva R
Turk J Med Sci; 2016 Apr; 46(3):626-40. PubMed ID: 27513235
[TBL] [Abstract][Full Text] [Related]
18. The synergistic effect of sex hormone-binding globulin and aromatase genes on polycystic ovary syndrome phenotype.
Xita N; Georgiou I; Lazaros L; Psofaki V; Kolios G; Tsatsoulis A
Eur J Endocrinol; 2008 Jun; 158(6):861-5. PubMed ID: 18505907
[TBL] [Abstract][Full Text] [Related]
19. Association of the CYP17 gene polymorphism with risk for uterine leiomyoma in Brazilian women.
Vieira LC; Gomes MT; Castro Rde A; de Souza NC; da Silva ID; Baracat EC; Girão MJ
Gynecol Endocrinol; 2008 Jul; 24(7):373-7. PubMed ID: 18645709
[TBL] [Abstract][Full Text] [Related]
20. A CYP17A1 gene polymorphism in association with multiple uterine leimyomas; a meta-analysis.
Pakiz M; Potocnik U; But I; Mujezinovic F
Cancer Biomark; 2010-2011; 8(1):29-34. PubMed ID: 21896988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
